Stay updated on Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page
- Check3 days agoChange DetectedAdded a Locations section with Texas and updated to revision v3.3.3. Removed the old Texas Locations label and the HHS Vulnerability Disclosure link (from v3.3.2).SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision label Revision: v3.3.2 was added and Revision: v3.2.0 was removed, indicating a minor version update to the page.SummaryDifference0.0%

- Check39 days agoChange DetectedThe top government funding status notice has been removed.SummaryDifference0.3%

- Check53 days agoChange DetectedResults section added to the Study Record, including the Results First Submitted and Results First Posted dates. This update provides posted results data and clarifies when results were made available.SummaryDifference0.3%

- Check82 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference2%

- Check89 days agoChange DetectedUpdate to version v3.1.0 replaces v3.0.2 and removes the Melanoma category; overall, a revision/version update with a taxonomy/content category change.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.